Skip to main content

Table 11 Adverse events

From: Review of the literature and individual patients’ data meta-analysis on efficacy and tolerance of nitroxoline in the treatment of uncomplicated urinary tract infections

Adverse events (AE)

 

Nitroxoline

Controls

 

Patients (total)

234 (100%)

232 (100%)

 

Patients with AEs#

23 (9.8%)

18 (7.8%)

Adverse events (total)

 

33

26

Nervous system disorders

Headache

3

4

 

Dizziness

-

3

Eye disorders

Eyelid swelling

1

-

Cardiac and circulation disorders

Circulation disorder

-

1

Gastrointestinal disorders

Dysgeusia

-

1

 

Nausea

9

3

 

Regurgitation

1

1

 

Gastralgia

4

3

 

Obstipation

-

1

 

Diarrhoea

5

-

Metabolim and nutrition disorder

Anorexia

1

-

Urinary disorders

Incontinence

1

-

Reproductive system disorders

Colpitis

1

1

 

Fluor vaginalis

1

-

 

Tubal tumor

-

1

Immune system disorders

Allergy

1*

1

Skin and subcutaneous tissue disorders

Itching

1

1

 

Urticaria

1

1

 

Herpes labialis

-

1

General disorders

Intolerance

1

-

 

Weakness

1

-

 

Fever

1

-

Musculoskeletal, connective tissue and bone disorders

Back pain

-

1

 

Flank pain

-

2

 

Leg pain

-

1

  1. #comparison of nitroxoline vs. controls (logistic regression with random center effect) p = 0.360; *with papules/pustules.